Updates are available Correction dated 2020-06-18
Click to view Correction: https://doi.org/10.1038/s41556-020-0544-6
-
Authors
Arwert, Esther N.
Milford, Emma L.
Rullan, Antonio https://orcid.org/0000-0002-7365-9629
Derzsi, Stefanie
Hooper, Steven
Kato, Takuya
Mansfield, David
Melcher, Alan
Harrington, Kevin J.
Sahai, Erik https://orcid.org/0000-0002-3932-5086
-
Funding
Funding for this research was provided by:
Cancer Research UK (FC001144)
Cancer Research UK (FC001144)
Cancer Research UK (FC001144)
Cancer Research UK (FC001144)
Cancer Research UK (FC001144)
Cancer Research UK (FC001144)
Cancer Research UK (A23275)
Cancer Research UK (A23275)
Cancer Research UK (FC001144)
RCUK | Medical Research Council (FC001144)
RCUK | Medical Research Council (FC001144)
RCUK | Medical Research Council (FC001144)
RCUK | Medical Research Council (FC001144)
RCUK | Medical Research Council (FC001144)
RCUK | Medical Research Council (FC001144)
RCUK | Medical Research Council (FC001144)
Wellcome Trust (FC001144)
Wellcome Trust (FC001144)
Wellcome Trust (FC001144)
Sociedad Española de Oncología Médica
Wellcome Trust (FC001144)
DH | National Institute for Health Research
- License Information
-
More Information
Article History
Received: 15 October 2018
Accepted: 25 April 2020
First Online: 1 June 2020
Change Date: 18 June 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41556-020-0544-6
Competing interests
: E.S. and E.M. received research funds from GlaxoSmithKline through a Biotechnology and Biological Sciences Research Council–GlaxoSmithKline CASE Fellowship. The other authors declare no competing interests.
